Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

Acquired Sigma-Aldrich businesses part of Merck's Africa growth plan

26-Nov-2015 - New acquisition Sigma Aldrich will play a part in African growth plans in addition to giving it a presence in the preclinical services sector says Merck*.

Bigger in Japan: Biopta CEO predicts preclinical CRO business growth under new owners

26-Nov-2015 - Preclinical CRO Biopta will add stem cell programming tech to its offering, expand in Japan and nearly double its workforce under new owner, Reprocell.

Reprocell buys into cell therapy discovery services sector with Biopta takeover

25-Nov-2015 - Reprocell has entered the CRO space through the acquisition of preclinical discovery services Biopta.

CRL buys German mouse model CRO for €34m

24-Nov-2015 - Charles River has acquired German preclinical CRO Oncotest GmbH in a €34m ($36m) cash deal.

Cyprotex: Predictive toxicology tech will help pharma cut animal study spending

23-Nov-2015 - Cyprotex has expanded its toxicology offering with a new in silico technology it claims will reduce preclinical costs and cut the number of animal studies required.

Abcam buys AxioMx for antibody production technology

23-Nov-2015 - Abcam has acquired monoclonal antibody production specialist AxioMx in a deal worth up to $45m (€42m).

Sanofi strategic research agreement bolsters Evotec's topline

12-Nov-2015 - A strategic discovery partnership signed with Sanofi in March has helped grow Evotec's revenues by over 50%, the German CRO reports.

CRL plans to pounce as pharma outsources more early discovery

05-Nov-2015 - Charles River has reported strong Q3 sales despite weakness in Japan and plans to grab space in emerging early discovery, bio-testing and Chinese markets.

Covance toxicology capacity use still suboptimal despite improvements

28-Oct-2015 - Covance has reported capacity use at its preclinical toxicology business is in the 70% range, meaning it is still well below optimal levels despite recent improvements.

SNBL animal models win anti-terror attack contract

28-Oct-2015 - CRO SNBL USA, daughter company of Shin Nippon, has won a BARDA contract for animal models to treat injuries from chemical, radiological and nuclear attack.

Intertek's CA bioanalytical lab expansion latest response to biopharma demand

22-Oct-2015 - An expanded San Diego facility will support demand for preclinical and clinical development services driven by the growth in the antibody and biosimilar sector, Intertek says.

CRL bags three new preclinical services contracts

12-Oct-2015 - Preclinical CRO Charles River Laboratories has inked a number of deals across its discovery service business.

Chemical synthesis of IL-10 cytokine 90% cheaper than bioproduction, Provepep

08-Oct-2015 - Chemical synthesis of peptides and proteins can be done at a tenth of the cost of bioproduction says French chemistry specialist Provepep.

Repositive launches free gene database for drug researchers

07-Oct-2015 - A UK firm has launched a searchable database of genomic data from sources all over the world that it says will accelerate development of personalised medicines.

“Money has returned to the market”: Envigo mulls biopharma role in preclinical recovery

29-Sep-2015 - Demand for biopharmaceutical testing is in part responsible for higher capacity utilisation but, despite encouraging signs, it is too early to say if preclinical pricing will improve accordingly says Envigo.

Drug delivery tech contractor 3M teams with MedImmune on cancer drug development

28-Sep-2015 - Contractor 3M Drug delivery has licensed a molecule with potential as a cancer treatment to MedImmune.

Venn offers $7.2m for Kinesis to boost toxicology testing offering

22-Sep-2015 - Venn Life Sciences has bid €6.5m ($7.2m) for preclinical CRO Kinesis Pharma BV in a move prompted by increased Big Pharma focus of efficient early phase drug discovery.

Covance mulls sacking 130 UK staff at ex Sanofi site; Opens 2nd cGMP pharmacy in US

22-Sep-2015 - Covance has warned 130 UK employees they could lose their jobs next month when a 5-year contract with Sanofi comes to an end.

Labcorp: Covance not adding capacity despite preclinical recovery

18-Sep-2015 - Covance will not add more capacity in the near future despite increased demand and improving preclinical sector pricing, Labcorp’s management says.

News in brief

Selvita opens two US offices and sets up Selvita Inc

18-Sep-2015 - Polish preclinical services company Selvita has opened offices in Boston and San Francisco in the US citing proximity to customers as the driver.

Evotec ups 2015 forecast for second time in two months citing Big Pharma deals

16-Sep-2015 - Evotec AG has raised its revenue expectations twice in as many months, predicting that contracts with Big Pharma customers will drive growth.

Pfizer calls on Evotec for tissue fibrosis drug discovery

10-Sep-2015 - Evotec has added Pfizer to its roster of Big Pharma partners through a drug discovery agreement focused on tissue fibrosis.

Agilent adding metabolism analysis tech in $235m Seahorse acquisition

10-Sep-2015 - Agilent Technologies has inked a deal to acquire Seahorse Bioscience, adding a cell metabolism analysis platform to its lead development and preclinical offerings.

Bear-faced lie? Amgen retracts diabetes-obesity paper due to data manipulation

02-Sep-2015 - Amgen has retracted a study showing how grizzly bears could hold the key to understanding diabetes after one of the authors was found to have manipulated data.

WuXi enters strategic lab testing partnership with HK-based firm

28-Aug-2015 - WuXi PharmaTech has signed a strategic partnership deal to provide exclusive laboratory testing services to Hong Kong-headquartered Lee’s Pharmaceutical.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...